Humana Analysts More Bullish After Health Insurance Fee RepealHomeMailNewsFinanceSportsEntertainmentSearchMobileMoreYahooSearchNo matching results for ''Tip: Try a valid symbol or a specific company name for relevant resultsSign inMailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Humana Analysts More Bullish After Health Insurance Fee RepealShanthi RexalineBenzingaJanuary 3, 2020ReblogShareTweetShareHumana Inc (NYSE: HUM) is likely to benefit from the permanent repeal of the health insurance fee, or HIF, beginning Jan. 1, 2021, rendering the stock more attractive, according to sell-side analysts.The AnalystsJPMorgan analyst Gary Taylor reiterated an Overweight rating on Humana and raised the price target from $437 to $448. Goldman Sachs analyst Stephen Tanal has a Buy rating on Humana and lifted the price target from $397 to $425. Humana Well-Positioned To Gain Market Share In 2021, JPMorgan Says The consensus estimates for Humana haven't yet reflected the anticipated improvement in Medicare Advantage benefits, enrollments and margin in 2021-2022, stemming from the repeal of the HIF, Taylor said in a Friday note. Humana has a greater ability to boost benefits and enrollment versus peers for 2021 given that it had the most conservative benefits and margin balance for 2020, the analyst said. See Also: Analysts Offer Positive Prognosis For UnitedHealth After Investor DayJPMorgan raised its 2021 retail MA enrollment growth estimate for Human from 7.5% to 9% but lowered its retail MA pretax margin outlook for 2021 from 4.3% to 3.6%, reflecting a material strategic benefit investment.The analyst also increased the 2021 EPS estimate for the company from $21.44 to $21.98 and introduced a Street-high EPS estimate of $25.59.Humana continues to be one of JPMorgan's top picks in 2020."We call HUM 'the simplest story in healthcare', nearly a pure-play on strong organic Medicare Advantage (MA) industry enrollment growth and well positioned to gain market share in 2021," Taylor said."The scarcity value of organic growth stories like HUM will command a premium P/E valuation to the S&P 500."HIF Repeal Most Material To Humana, Goldman Says Meaningful upward estimate revisions to the 2021 consensus estimates for Humana are likely due to the HIF repeal, Tanal said in a Friday note. MA managed care organizations have been the most challenged by the HIF, given the lack of reimbursement for its pre-tax impact, which works out to $1.2 billion for Humana in 2020, the analyst said. Goldman's 2021 adjusted EPS estimate for Humana is being adjusted 10% higher from $21.95 to $24.10, 12% above the current consensus. The firm sees the HIF's repeal as most material for Humana.Price ActionHumana shares were trading 1.17% higher at $367.50 at the time of publication Friday. Latest Ratings for HUM Date Firm Action From To
Jan 2020
Maintains
Overweight
Jan 2020
Maintains
Buy
Dec 2019
Maintains
Overweight
View More Analyst Ratings for HUM
View the Latest Analyst Ratings0See more from BenzingaThe Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate MergerPulmatrix Shares Soar On Licensing Agreement With Johnson & JohnsonCiti Downgrades Intercept, Says NASH Launch Is Appropriately Priced In© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextJPMorgan Joins Goldman in Cutting Profit Estimates for S&P 500BloombergHumana Extends Value-based Care Services in North CarolinaZacksRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoMost face masks won’t protect you from the coronavirusYahoo FinanceStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceSomething 'dangerous' is happening beneath the surface of the market selloffYahoo FinanceMarket Recap: Friday, Dec. 13Yahoo Finance VideoBeyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'Yahoo Finance